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Abstract
Background: Genotyping of Plasmodium falciparum based on PCR amplification of the polymorphic genes encoding the
merozoite surface proteins 1 and 2 (msp1 and msp2) is well established in the field of malaria research to determine the
number and types of concurrent clones in an infection. Genotyping is regarded essential in anti-malarial drug trials to
define treatment outcome, by distinguishing recrudescent parasites from new infections. Because of the limitations in
specificity and resolution of gel electrophoresis used for fragment analysis in most genotyping assays it became necessary
to improve the methodology. An alternative technique for fragment analysis is capillary electrophoresis (CE) performed
using automated DNA sequencers. Here, one of the most widely-used protocols for genotyping of P. falciparum msp1
and msp2 has been adapted to the CE technique. The protocol and optimization process as well as the potentials and
limitations of the technique in molecular epidemiology studies and anti-malarial drug trials are reported.
Methods: The original genotyping assay was adapted by fluorescent labeling of the msp1 and msp2 allelic type specific
primers in the nested PCR and analysis of the final PCR products in a DNA sequencer. A substantial optimization of the
fluorescent assay was performed. The CE method was validated using known mixtures of laboratory lines and field
samples from Ghana and Tanzania, and compared to the original PCR assay with gel electrophoresis.
Results: The CE-based method showed high precision and reproducibility in determining fragment size (< 1 bp). More
genotypes were detected in mixtures of laboratory lines and blood samples from malaria infected children, compared to
gel electrophoresis. The capacity to distinguish recrudescent parasites from new infections in an anti-malarial drug trial
was similar by both methods, resulting in the same outcome classification, however with more precise determination by
CE.
Conclusion: The improved resolution and reproducibility of CE in fragment sizing allows for comparison of alleles
between separate runs and determination of allele frequencies in a population. The more detailed characterization of
individual msp1 and msp2 genotypes may contribute to improved assessments in anti-malarial drug trials and to a further
understanding of the molecular epidemiology of these polymorphic P. falciparum antigens.
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Background
Genotyping of Plasmodium falciparum parasite popula-
tions is performed in order to determine the types and
number of parasite clones in an infection. In molecular
epidemiological studies of malaria, genotyping is used to
study the genetic diversity of infections in relation to var-
ious factors such as transmission intensity and host
immunity. The method enables studies of parasite popu-
lation dynamics and tracking of individual clones over
time. Genotyping is, therefore, recommended in anti-
malarial drug trials to define treatment outcome by distin-
guishing recrudescent parasites from new infections [1].
The most widely used techniques for genotyping P. falci-
parum infections are based on polymerase chain reaction
(PCR) amplification of the polymorphic genes encoding
the merozoite surface proteins 1 and 2 (MSP1 and MSP2)
and the glutamate-rich protein (GLURP) [2-8]. Since these
are single copy genes, amplification generates DNA frag-
ments corresponding to individual parasite clones. The
methods used for genotyping msp1 and msp2 often
include a two-step reaction with a primary amplification
of the entire polymorphic gene segments, block 2 of msp1
and block 3 of msp2, followed by a nested reaction target-
ing the allelic type-specific regions within these blocks
[4,5,7,8]. The PCR products are usually distinguished
from each other based on fragment size after being sepa-
rated by gel electrophoresis and visualization with ethid-
ium bromide staining and UV transillumination.
Interpretation of agarose gels and comparisons between
separate runs is, however, not always straightforward,
since differences between fragments and exact base pair
(bp) size variations are often difficult to detect using the
naked eye or even with digital software analysis. Indeed,
variations in fragment migration and gel resolution stress
the need for more specific and reproducible methods.
An alternative technique for fragment analysis is capillary
electrophoresis (CE) performed using automated DNA
sequencers. When applied to genotyping, the method is
based on PCR amplification with fluorescently-labeled
oligonucleotide primers, followed by fragment separation
by electrophoresis in fine capillaries and detection by
laser. The fragments' relative base-pair sizes are estimated
in relation to the migration time of an internal fluorescent
size standard using specific software. Allelic types are dis-
tinguished using primers labeled with different fluores-
cent dyes, which are detected as different colours upon
laser excitation.
CE has successfully been used for typing several different
microorganisms including Mycobacterium tuberculosis,
Legionella pneumophilia, Bacillus anthracis, and Escherichia
coli [9-12]. The technique has also been applied to the
genotyping of P. falciparum msp2 polymorphism, both in
an allele type-specific [13] and non-specific manner
[14,15]. Compared to a PCR-based restriction fragment
length polymorphism method (PCR-RFLP), a CE-based
nested genotyping method revealed an improved resolu-
tion while detecting a higher number of msp2 genotypes
per infection in a high transmission area [13]. Another
CE-based assay, based on single msp2 amplification, has
also been used for quantifying individual clones in multi-
clonal infections [14,15]. The potential of CE-based tech-
niques has led to a recommendation by experts in the
field to use automated sequencers for fragment analysis
within the Medicines for Malaria Ventures/World Health
Organization (MMV/WHO) protocol for genotyping in
clinical trials on anti-malarial drug efficacy [1].
Here, one of the most widely used assays for genotyping
P. falciparum populations, using nested allelic type specific
amplification of both msp1 and msp2 [7,16] was adapted
to CE. The CE-based method revealed several advantages
compared to the standard gel electrophoresis for deter-
mining fragment size including improved resolution and
allelic determination, and high throughput. Here the pro-
cedure and the optimization process as well as the poten-
tials and limitations of the technique in molecular
epidemiology studies and anti-malarial drug trials are
reported.
Methods
Laboratory cultured parasite lines
The laboratory-cultured P. falciparum lines F32, K1, 7G8
and TM180 were used as positive controls. Parasite DNA
was extracted from red blood cell cultures using E.N.Z.A
Blood DNA Kit (Omega Bio-Tek, Inc. Doraville, GA, USA)
according to the manufacturer's instructions.
Field samples
Intermittent preventive treatment trial
Finger prick blood samples collected on filter paper from
240 microscopy-positive children between three and 59
months of age, during a trial of intermittent preventive
treatment (IPTc) in Hohoe, Ghana [17] were genotyped in
order to evaluate the method in natural infections in a
highly endemic area. DNA was extracted from whole
blood spots using ABI Prism 6100 Nucleic Acid PrepSta-
tion (Applied Biosystems, Foster City, CA, USA). Written
consents were obtained from the participating children's
caregivers. Ethical approval was received from the Ethical
Review Committee of Ghana Health Services and from the
Regional Ethical Review Board in Stockholm, Sweden.
Anti-malarial drug trial
Finger prick blood samples collected on filter paper from
57 children, below 5 years of age, with acute, uncompli-
cated P. falciparum malaria participating in an efficacy trial
of artesunate + amodiaquine versus artemether-lumefan-
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trine in Zanzibar, Tanzania (Mårtensson et al, manuscript
in preparation), were genotyped in order to evaluate the
method in an anti-malarial drug trial. Paired blood sam-
ples collected before the initiation of treatment and at
recurrent parasitaemia between days 21–42 of follow up
were analysed (n = 114). DNA was extracted from blood
spots using ABI Prism 6100 Nucleic Acid PrepStation
(Applied Biosystems). Informed consent was obtained
from parents of enrolled children. The study obtained eth-
ical approval from the Zanzibar Medical Research Council
and from the Regional Ethical Review Board in Stock-
holm, Sweden.
Original msp1 and msp2 genotyping assays
PCR method (non-fluorescent)
Genotyping of P. falciparum parasites was performed with
a nested PCR assay based on the amplification of msp1
and msp2 as described in detail elsewhere [7,16] with
some modifications. In brief, in the primary reaction, the
oligonucleotide primers span the entire genetic segments,
block 2 for msp1 and block 3 for msp2 (Table 1). In the
nested reaction, separate primer pairs target the respective
allelic types of msp1 (K1, MAD20, and RO33) and msp2
(FC27 and IC – elsewhere also referred to as 3D7) (Table
1).
Primary reaction
The final concentration of the master mix consisted of 1×
PCR buffer, 2 mM MgCl2, 125 μM dNTP and 0.02 units/
μl of AmpliTaq® DNA polymerase (Applied Biosystems),
and 250 nM each of the outer primer pairs msp1 forward
(F)/reverse (R) and msp2 F/R. For the laboratory lines, 2 μl
DNA was used as a template with the volume correspond-
ing to 1 μl of whole blood. The amount of field sample
DNA used was 2 μl and 3 μl from Zanzibar and Ghana,
respectively corresponding to 0.1–0.3 μl whole blood
assuming a blood volume per spot of 10–20 μl. The cycle
conditions were: initial denaturation at 95°C for 5 min
followed by 25 cycles of annealing at 58°C for 2 min,
extension at 72°C for 2 min, denaturation at 94°C for 1
min with a final round of 58°C for 2 min and 72°C for 5
min.
Nested reaction
The final concentration of the master mix consisted of 1×
PCR buffer, 1 mM MgCl2, 125 μM dNTP and 0.02 units/μl of AmpliTaq® DNA polymerase, and 250 nM of the
respective msp1 allelic type-specific primers (K1, MAD20,
and RO33 types) and 125 nM of the respective msp2 type
primers (FC27 and IC types) in separate reactions.
For the respective nested reactions, 1 μl product from each
primary reaction was used as a template. For the amplifi-
cation of the msp1 allelic types, the cycle conditions were
as follows: initial denaturation at 95°C for 5 min fol-
lowed by 30 cycles of annealing at 61°C for 2 min, exten-
sion at 72°C for 2 min, denaturation at 94°C for 1 min,
and a final round at 61°C for 2 min and 72°C for 5 min.
Table 1: Oligonucleotide primers for msp1 and msp2 genotyping and fluorescent modifications for the CE method
Primer sequencesa Fluorophore modificationb
Segment-specific primers for block 2 of msp1 and block 3 of msp2
In the primary reaction
msp1 F 5'-CTAGAAGCTTTAGAAGATGCAGTATTG-3'
msp1 R 5'-CTTAAATAGTATTCTAATTCAAGTGGATCA -3'
msp2 F 5'-ATGAAGGTAATTAAAACATT GTCTATTATA-3'
msp2 R 5'- CTTTGTTACCATCGGTACATTCTT-3'
Allelic type-specific primers for msp1 in the nested reaction
K1 F 5'- AAATGAAGAAGAAATTACTACAAAAGGTGC-3' 7 bp-tail
K1 R 5'- GCTTGCATCAGCTGGAGGGCTTGCACCAGA-3' NED™ (yellow)
MAD 20 F 5'- AAATGAAGGAACAAGTGGAACAGCTGTTAC -3' 7 bp-tail
MAD 20 R 5'- ATCTGAAGGATTTGTACGTCTTGAATTACC'-3' PET® (red)
RO33 F 5'- TAAAGGATGGAGCAAATACTCAAGTTGTTG-3' 7 bp-tail
RO33 R 5'- CATCTGAAGGATTTGCAGCACCTGGAGATC-3' VIC® (green)
Allelic type-specific primers for msp2 in the nested reaction
FC27 F 5'- AATACTAAGAGTGTAGGTGCARATGCTCCA-3' 7 bp-tail
FC27 R 5'- TTTTAT TTG GTGCAT TGCCAGAAC TTG AAC-3' 6-FAM™ (blue)
IC c F 5'- AGAAGTATGGCAGAAAGTAAKCCTYCTACT-3' 7 bp-tail
ICc R 5'- GATTGTAATTCGGGGGATTCAGTTTGTTCG-3' VIC® (green)
a Primer sequences according to the original method [7,16]
b Modification of the primers used in the CE-based method
c Also referred to as 3D7 type
F = forward R = reverse
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For the msp2 allelic types, the cycle conditions were as fol-
lows: initial denaturation at 95°C for 5 min, followed by
30 cycles of annealing at 58°C for 1 min, extension at
72°C for 1 min followed by 94°C for 30 sec, and a final
round at 58°C for 1 min and 5 min at 72°C. All amplifi-
cations were performed on 96-well plates with a total reac-
tion volume of 20 μl per well.
Fragment analysis by gel electrophoresis
The amplified products from the nested reaction were sep-
arated using electrophoresis on a 2% high resolution aga-
rose gel (Agarose 3:1 HRB™, Amresco, Inc, Cleveland, OH,
USA) in 1× TBE buffer (100 mM Tris, 100 mM boric acid,
5 mM EDTA [pH 8.0]) and, following staining with ethid-
ium bromide, visualized with UV light in a Universal
hood II (Bio-Rad Laboratories, Inc, Hercules, CA, USA).
Fragment size was estimated in relation to a 100 base-pair
DNA ladder (Invitrogen Corporation, Carlsbad, CA, USA)
both by the naked eye and in a GelDoc Xr system with
Quality One® analysis software version 4.4.1 (BioRad).
Modified genotyping assays for capillary electrophoresis
Fluorescent PCR method
The PCR protocol for the CE method was based on the
msp1 and msp2 genotyping assay described above [7,16].
The primary PCR reaction was identical to the original
assay. In the nested reaction, the allelic type-specific prim-
ers were modified as follows: (i) the forward primers were
tailed with a 7-bp tail (Applied Biosystems) at the 5'-end
in order to promote the non-template adenosine (A) addi-
tion by the Taq DNA polymerase at the 3' end of the PCR
products [18], (ii) the reverse primers were labeled with
different fluorophores at the 5'-end: msp1 K1 with NED™
(yellow), MAD 20 with PET® (red), and RO33 with VIC®
(green); msp2 FC27 with 6-FAM™ (blue) and IC with VIC®
(green) (Table 1). The addition of the tail promoting the
additional A counteracts amplification of fragments dif-
fering with a single nucleotide i.e. fragments ± A. Moreo-
ver, due to the addition of the tail on the forward primers,
all GeneMapper®-estimated bp sizes presented in this
paper include an extra 8 bp segment (7 bp tail +A).
Nested reaction
For the fluorescent assay, different modifications of the
original nested reaction were evaluated. The final protocol
included the following adjustments: (i) the concentration
of all msp1 and the msp2 FC27 allelic type-specific primer
pairs was decreased to 125 nM each (F/R); (ii) in the msp2
IC reaction, the primers were increased to 300 nM each (F/
R) and the AmpliTaq® DNA polymerase to 0.05 units/μl;
(iii) the number of cycles was reduced to 23 in all nested
fluorescent PCR amplifications. All other concentrations
and conditions were kept identical to the original nested
reaction.
Fragment analysis by capillary electrophoresis
Fragment analysis was performed on a 3730 DNA
sequencer (Applied Biosystems) equipped with 48 capil-
laries (36 cm), using POP-7™ polymer (Applied Biosys-
tems). From the nested reaction, 1 μl product was added
to 9 μl Hi-Di formamide (Applied Biosystems) and 0.5 μl
size standard (GS™-LIZ® 1200, Applied Biosystems) per
well on 96-well plates. Resulting peaks were diluted 1:10
or 1:20 in sterile water after initial screening to achieve
peaks < 8000 rfu. The size standard contains 73 single-
stranded DNA fragments ranging in size from 20 bp to
1200 bp.
The msp1 and msp2 markers were run separately during
CE, due to competition for separation between the
smaller VIC-labeled msp1 RO33 fragments and the larger
VIC-labeled msp2 IC fragments. The sample volume in the
capillary system was adjusted depending on the number
of allelic types analysed simultaneously; 10.5 μl when the
respective allelic types were run separately, 11.5 μl for
multiplex msp2 (FC27 + IC), and 12.5 μl for multiplex
msp1 (K1+MAD20+RO33). The separation was run at 8.0
kV for 4000 sec. The results were interpreted using Gen-
eMapper® Software version 4.0 (Applied Biosystems).
Multiplex versus simplex amplification in the fluorescent nested 
reaction
To increase the CE method's throughput, a multiplex
approach to the nested PCR reaction was evaluated. The
allelic types were run separately for msp1 and msp2 and in
mixtures (multiplex msp1 and msp2). The allelic type spe-
cific primers were mixed accordingly; msp1
K1+MAD20+RO33, msp2 FC27+IC. The risk of hybrid and
artifact products was also evaluated in an msp2 type-spe-
cific hybrid assay (FC27 F-7 bp tail/IC R-VIC and FC27 R-
6-FAM/IC F-7 bp tail) in two separate nested reactions.
The amount of AmpliTaq® DNA polymerase was increased
to 0.05 units/μl in the multiplexed and in the hybrid
assays. All other concentrations and conditions were kept
identical to the fluorescent nested reaction. DNA suspen-
sions from laboratory lines (F32, K1, and 7G8) corre-
sponding to 1000, 50 and 10 parasites/μl, respectively,
and a set of field samples from Ghana (n = 81) were ana-
lysed. The multiplex and simplex nested reactions were
both followed by multiplexed CE for msp1 and msp2. All
PCR products were diluted 1:10 before carrying out CE.
Determination of sensitivity, specificity, and 
reproducibility
DNA from laboratory lines (F32, K1, and 7G8) were
diluted stepwise in sterile water, to concentrations corre-
sponding to 5,000, 1,000, 500, 100, 50, 10, 5 and 1 para-
sites/μl whole blood (assuming a haematocrit of 50%),
and mixed in different proportions (10:1,000, 500:500,
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and 1,000:10 parasites/μl). All PCR amplifications were
repeated at least twice to assess the reproducibility of
detection and size determination.
The msp1 and msp2 nested amplicons from the laboratory
lines were sequenced to validate the accuracy of size call-
ing of CE. The PCR products were purified using Montage®
PCR Filter Units (Millipore, Billerica, MA, USA) prior to
sequencing (performed by Uppsala Genome Centre, Upp-
sala, Sweden). Since fluorescently-labeled PCR products
cannot be sequenced due to dye interference, the original
allelic type-specific primers were used for amplification
before sequencing. The sequences were analysed using the
DNA Sequencing Analysis Software version 5.2 (Applied
Biosystems).
The accuracy of relative quantification by CE-based geno-
typing was evaluated by calculating the ratios between the
area under the curve (AUC) values, corresponding to the
amount PCR product, in mixtures of laboratory lines
(99:1, 50:50, 1:99) of the same or different msp2 allelic
types, thus labeled with the same or different fluorescent
dyes. The ratio between alleles was expressed as AUC
value for one allele/total AUC values for all alleles within
that sample. The calculated proportions were compared
with the actual proportions of the respective lines. All PCR
products were diluted 1:20 before CE.
Enumeration of clones in natural infections
The CE method was compared to gel electrophoresis for
its ability to distinguish separate alleles and determine the
number of concurrent clones in samples collected from
240 microscopy- positive children during an IPTc trial in
Ghana. All fluorescent products were diluted 1:10 before
CE. Fragments were allocated to size bins of 3 bp to deter-
mine allele frequencies.
Distinguishing recrudescent from new infections
Paired samples (n = 114) from 57 children participating
in an anti-malarial drug trial in Zanzibar, Tanzania, were
genotyped to compare CE and gel electrophoresis in their
ability to determine recrudescent versus new infections
during follow-up after treatment. Genotyping was done
stepwise with an initial msp2 followed by msp1 genotyp-
ing of the paired blood samples found to have at least one
identical msp2 allele before and after treatment. Paired
samples were placed randomly on the 96-well plates for
analysis by CE, while being run on adjacent lanes on aga-
rose gel. Using CE, alleles were considered to be the same
if the fragments differed less than 1 bp. With gel electro-
phoresis, the fragments were compared using the naked
eye and estimated to be of the same length.
Results
Fluorescent artifacts
The PCR assay with fluorescently labeled primers for the
CE method was initially set up with the same conditions
as the original gel electrophoresis method. Optimization
of several parameters was, however, required. During the
process different types of artifacts were identified on the
electropherograms not detected on corresponding gels.
Fluorescent background and non-specific low background artifacts
An inherent fluorescent background was detected in all
CE runs (Figure 1A, right). The relative fluorescent unit
(rfu) value for the background was generally below 50
units. A slightly higher background of non-specific artifact
peaks was occasionally seen in field samples, independent
of parasite densities (Figure 1A, left). This background was
reduced by optimizing primer concentrations and the
amount of DNA template. A cut-off value of 300 rfu [13]
was introduced to simplify interpretation and identifica-
tion of true alleles in the optimized assay.
Companion peaks
Artifact peaks with a typical characteristic were distin-
guished in samples known to contain single clones. These
peaks were wider and rounder than the true allele peak,
and were positioned 5 to 20 bp left of a true allele peak
(Figure 1B). The rfu values of these peaks, which we
termed "companion peaks", were often similar to, and
even higher than, the true alleles. Occasionally, they
appeared to reduce the rfu value of the true allele to values
below cut-off. These artifacts were run-specific, that is,
when present within a run they were present in most sam-
ples on that plate. However, these artifacts have only been
seen in four CE runs so far. When the PCR products from
the same samples were separated by gel electrophoresis,
only the fragments corresponding to the true allele were
detected, suggesting companion peaks to be purely fluo-
rescent artifacts. Diluting the nested PCR products in
water before CE removed the companion peaks and
resulted in an increased rfu of the true alleles.
Stutter peaks
Amplification of laboratory lines at high parasite densities
generated artifact peaks in strict repetitive patterns, stutter
peaks, at base-pair intervals specific for the respective
clones and allelic types. Amplification of msp2 FC27 of the
K1 laboratory line generated peaks situated approximately
36 bp apart (Figure 1C). For the F32 clone, the msp2 IC
amplification resulted in stutter peaks at 12 bp intervals,
and for msp1 MAD20, 18 bp apart. This type of stutters
was not detected in any of the msp1 K1 or RO33 amplifi-
cations. The stutter peaks were all of similar height and
lower than the true allele (Figure 1C). In 18 msp2 runs of
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Screenshot of electropherogram (GeneMapper® software) displaying different artifacts: A) fluorescent background (right) and non-specific low background (left) in a field sample with 2 msp1 K1 allelesFigure 1
Screenshot of electropherogram (GeneMapper® software) displaying different artifacts: A) fluorescent back-
ground (right) and non-specific low background (left) in a field sample with 2 msp1 K1 alleles. The red striped line 
indicates the cut-off at 300 relative fluorescent units (rfu). B) Companion peak, to the left of a true peak of an msp1 K1 allele 
from a single laboratory line. C) Stutter peaks in a sample with the K1 laboratory line amplified with msp2 FC27 primers. The 
y-axis depicts the rfu while fragment size (sz) in base pair and rfu height (ht) for individual alleles is depicted on the x-axis. The 
rfu scale on the y-axis has been adjusted to focus on the artifacts.
 Amsp1 K1 allele msp1 K1 allele 
Non-specific low ar tifact peaks    Fluorescent background 
 B 
msp1 K1 allele     Companion peak 
C 
   msp2 FC27 allele 
              Stutter  peaks 
  36 bp  36 bp   36 bp   36 bp 
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the K1 line in different dilutions, the FC27 type-specific
stutter peaks never exceeded 6% of the rfu value of the true
allele peak. In the only field sample in which a 36 bp pat-
tern was detected, the rfu values of these FC27 type-spe-
cific stutter peaks were below 14% of the rfu of the true
allele.
Another stutter pattern was seen in 17 of 54 samples from
Ghana with a msp2 FC27-type peak of 383 bp accompa-
nied by two smaller peaks at 96–97 bp intervals, at 286 bp
and 189 bp. These peaks were never detected alone, and
were all < 10% of the 383 bp allele height, except in one
sample where they corresponded to 40% of the height.
When these products were run on a gel, only one band
corresponding to the 383 bp allele was seen, suggesting
that the two smaller peaks were artifacts. In two samples
from Ghana, an msp1 MAD20 allele, which was also
detected as a single band on the gel, appeared with stutter
peaks situated approximately 27 bp and 9 bp apart,
respectively.
Optimization of the fluorescent PCR assay and capillary 
electrophoresis
Several parameters in the fluorescent nested reaction and
product preparation prior to CE were optimized in order
to reduce the artifacts described above and ensure sus-
tained sensitivity.
Primer concentration
Reduced primer concentrations (200, 150, 125, 100, and
75 nM) of the allelic type-specific primers in the nested
reaction resulted in a considerable reduction in the height
of true allele peaks as well as the stutters and non-specific
low artifact peaks. Concentrations below 125 nM, how-
ever, affected detection sensitivity in low parasite density
controls (5 parasites/μl). The primer concentration for all
msp1 allelic types and for the msp2 FC27 was therefore set
to 125 nM of F/R primers each.
The msp2 IC assay needed a more extensive optimization
in order to attain satisfactory sensitivity. Different concen-
trations of MgCl2 and dNTP as well as annealing tempera-
tures (55, 53 and 50°C) in the nested reaction did not
affect the outcome. The optimal amplification with msp2
IC primers was achieved with a primer concentration of
300 nM of F/R each and 0.05 units AmpliTaq® DNA
polymerase.
To reduce the stutter peaks in the msp2 FC27 runs, high
performance liquid chromatography (HPLC) purified (by
manufacturer, Applied Biosystems) reverse primers (6-
FAM-labeled) as well as AmpliTaq®Gold DNA Polymerase
(Applied Biosystems) with hot-start activation were
tested. Both approaches reduced the general peak height
but did not considerably affect the presence of stutter
peaks.
Amount of DNA template
Different amounts of DNA template (3 μl, 2 μl, and 1 μl)
from the K1 line and field samples from Ghana (n = 32)
were added in the primary PCR reaction. One μl of DNA
generally resulted in fewer stutter peaks and non-specific
low artifact peaks, however, also resulting in allele drop-
out and negative results in 8/35 otherwise positive sam-
ples. Although the amount of DNA affected the detection
and number of peaks, it did not affect, to any considerable
extent, the rfu height of peaks or the occurrence of stutters.
Number of PCR cycles
The relative fluorescent intensity of the stutter peaks
decreased when the number of cycles in the nested reac-
tion was reduced from 30 to 25 cycles. A further reduction
to 20 cycles almost completely eliminated the artifacts, yet
with a 10-fold reduction in sensitivity. A nested reaction
with 23 cycles, for all msp1 and msp2 allelic types, was
optimal with regards to sustained sensitivity and reduced
artifacts.
Dilution of nested PCR products prior to capillary electrophoresis
According to the manufacturer (Applied Biosystems), an
optimal analysis with the current genotyping assay should
not result in peaks higher than 8000 rfu. Peaks exceeding
20 000 rfu, however, occurred in samples with a wide
range of parasitaemias (range 120 to 98 600 parasites/μl).
Dilution of the final products from the nested reaction in
sterile water (1:5, 1:10, and 1:20) before carrying out CE
resulted in reduced rfu values, as well as elimination of
companion artifact peaks. Still, samples with low parasite
concentrations (5 parasites/μl) were occasionally left
undetected in 1:20 dilution, thus 1:10 dilutions were
most commonly used.
Increasing PCR throughput – multiplex versus simplex 
nested PCR
The ability to multiplex the nested reactions, that is,
simultaneous amplification with all the respective allelic
type-specific primers for msp1 and msp2, was evaluated on
laboratory lines (F32, K1, and 7G8) and 81 field samples
from Ghana. The same detection levels (10 and 50 para-
sites/μl) and the number of positive samples (n = 80)
were obtained for the two markers by both, multiplex and
simplex approaches, respectively. The number of detected
msp1 fragments was similar by simplex (213 fragments)
and multiplex PCR (215 fragments). For msp2, however,
the multiplexed assay detected more FC27 fragments (101
vs. 79) and fewer IC fragments (136 vs. 149) compared to
the simplex assay. The allelic type-specific primers were
also combined (FC27 F-7 bp tail/IC R-VIC and FC27 R-6-
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FAM/IC F-7 bp tail) in separate reactions. In this hybrid
assay, 16 additional fragments observed in multiplex PCR
as well as 26 additional FC27 and 13 IC fragments were
detected. Notably, the K1 clone, known to be a FC27 type
and not representing a crossing over between allelic types,
gave a positive result in the hybrid assay.
Detection sensitivity and specificity
To compare the sensitivity of detection, serial dilutions
and mixtures of the laboratory lines F32, K1, and 7G8
were analysed by CE and gel electrophoresis in the opti-
mized assay. A detection sensitivity of 5–10 parasites/μl
was found for both msp1 and msp2 markers by the respec-
tive methods (Table 2). In the mixtures, the dominating
genotype, for example, 1000 parasites/μl was always
detected by both methods. The low concentration geno-
type (10 parasites/μl), which was always detected in single
clone samples, was more often detected by CE when
mixed with another clone at a higher concentration (Table
2). The rfu values of the allele peaks were generally lower
in runs with multiple compared to single clones.
In high density samples (> 5000 parasites/μl), the gel
method often generated non-specific bands and smears,
whereas the CE-based method generated one single peak
on the electropherograms irrespective of parasite density
(Figure 2).
AUC-based quantification of proportions of laboratory
lines of the same allelic types was most accurate in mix-
tures with two clones at 50:50 and at 99:1 ratios (Addi-
tional file 1, Table S1) however, mixtures with three
clones at equal proportions resulted in highly inaccurate
quantifications. An even higher disagreement between
actual and observed compositions was found in mixtures
of clones of different allelic types, that is, different dye
labeling (Additional file 2, Table S2).
Fragment sizing and reproducibility
The CE assay was able to precisely determine fragment
sizes at the single base-pair level. This is illustrated in Fig-
ure 3 with five different msp2 IC type amplicons estimated
by the naked eye to be approximately 500 bp on an agar-
Table 2: Genotyping of msp1 and msp2 in laboratory lines in different dilutions and mixtures using CE and gel electrophoresis
msp1 msp2
K1 MAD20 RO33 FC27 IC
Lines Densitya CEb gelc CEb gelc CEb gelc CEb gelc CEb gelc
F32 1000 0 0 192.99 205.50 0 0 0 0 524.09 539.10
100 0 0 193.01 207.06 0 0 0 0 524.05 539.12
50 0 0 192.94 203.59 0 0 0 0 524.07 539.28
10 0 0 193.02 201.20 0 0 0 0 524.25 519.80
5 0 0 192.99 205.10 0 0 0 0 524.06 540.91
1 0 0 0 0 0 0 0 0 0 0
K1 1000 173.48 177.61 0 0 0 0 372.82 392.41 0 0
100 173.43 180.28 0 0 0 0 372.85 378.61 0 0
50 173.30 179.85 0 0 0 0 372.87 381.90 0 0
10 173.64 182.89 0 0 0 0 372.86 382.01 0 0
5 173.56 182.51 0 0 0 0 372.85 395.98 0 0
1 0 0 0 0 0 0 0 0 0 0
7G8 1000 0 0 0 0 157.06 165.55 0 0 493.14 488.25
100 0 0 0 0 157.35 162.95 0 0 493.13 488.21
50 0 0 0 0 157.23 167.94 0 0 493.16 472.87
10 0 0 0 0 157.33 160.40 0 0 493.19 515.93
5 0 0 0 0 157.19 165.92 0 0 0 508.05
1 0 0 0 0 0 0 0 0 0 0
F32/K1 1000/10 173.60 177.06 192.98 197.04 0 0 0 0 523.52 509.46
500/500 173.66 174.49 192.96 194.87 0 0 372.99 380.85 524.25 521.31
10/1000 173.69 182.86 193.02 192.74 0 0 372.96 379.48 524.19 519.79
K1/7G8 1000/10 173.64 178.01 0 0 157.31 152.59 372.97 364.85 493.51 483.32
500/500 173.60 175.39 0 0 157.34 161.56 372.98 363.65 493.43 485.01
10/1000 173.61 172.85 0 0 157.26 161.57 0 0 493.38 500.08
F32/7G8 1000/10 0 0 193.08 190.99 157.49 0 0 0 524.20/492.68 521.99/0
500/500 0 0 193.08 188.05 157.49 165.59 0 0 524.19/493.47 539.46/0
10/1000 0 0 193.07 183.33 157.52 163.02 0 0 524.08/493.41 0/493.20
a parasites/μl
b Fragment siz (bp) including 7 bp tail + A, determined by GeneMapper® soft ware after simplex PCR
c Fragment sizes (bp) determined by Quality One 4.4.1 analysis software
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Genotyping of msp2 of the F32 laboratory line in different concentrations exemplifies non-specific bands that often appear in high density sa ples following electrophoresis on aga ose gel (A) and the correspondi g electropherogram with a singl  peak correspo ding to the F32 allele (B)Fi ur  2
Genotyping of msp2 of the F32 laboratory line in different concentrations exemplifies non-specific bands that 
often appear in high density samples following electrophoresis on agarose gel (A) and the corresponding elec-
tropherogram with a single peak corresponding to the F32 allele (B).
Non-specific bands 
A
500050 000 0.5 p/μl  
B
50 000 p/μl 
5000 p/μl 
0.5 p/μl 
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ose gel, and the corresponding precise base-pair lengths
determined by GeneMapper® following CE.
Determining the fragment size of the laboratory lines in
repeated PCR and CE runs resulted in size variation < 0.5–
1 bp (Table 2), demonstrating high reproducibility and
precision. When the corresponding non-fluorescent prod-
ucts were analysed by software (Quality One), following
separation on gel, the fragments of the same products var-
ied by 2–16 bp when run in different lanes on the same
gel or between different runs.
Sequencing was performed for the msp1 and msp2 prod-
ucts (non-fluorescent) from the F32, K1, 7G8 and TM180
lines. The fragment sizes determined by GeneMapper®
software differed by ≤ 4 bp from the determined
sequences (including adjustments for the 7 bp tail and the
additional A), indicating a high accuracy in sizing by the
CE method.
The reproducibility of fragment sizing on different instru-
ments was tested by running a CE analysis of the same flu-
orescent msp2 FC27 and IC products from 83 samples (77
samples from the Ghana field trial and 6 positive con-
trols) on the 3730 DNA Analyzer available at the depart-
ment and on a similar instrument at the Uppsala Genome
Centre, Uppsala, Sweden. This resulted in similar preci-
sion in size determination of individual alleles (< 0.5 bp)
between the instruments.
Enumeration of clones in natural infections
The number of clones detected with the msp1 and msp2
markers using CE and gel electrophoresis was analysed in
240 microscopy-positive samples (parasite range 40–
162240 parasites/μl) from children in an IPT trial in
Ghana. Of these, 223 (93%) were positive for both mark-
ers using both methods. In 20 samples, stutter patterns
were detected by CE, as described above: one sample with
36 bp FC27 stutter pattern, two samples with MAD20
stutter peaks at 27 bp and 9 bp, and 17 samples with the
286 bp and 188 bp peaks together with a 383 bp FC27
allele. These stutter peaks were excluded from further
analysis. The number of msp1 and msp2 fragments
detected by CE was higher than with gel electrophoresis
(Kruskal-Wallis test; msp1 P = 0.002, msp2 P < 0.001)
(Table 3). When estimating allele frequencies, the frag-
ments were allocated into size bins of 3 bp. For the msp2
IC allelic type, 127 different fragment sizes resulted in 76
alleles. For the allelic types of msp1 and for the FC27 type
of msp2 binning did not affect the number of alleles. In
total 48 different msp1 and 96 different msp2 alleles were
distinguished in these 223 isolates.
Distinguishing recrudescence from reinfection in anti-
malarial drug trials
Paired blood samples (n = 114) collected on filter paper
from 57 children enrolled in an anti-malarial drug trial in
Zanzibar were analysed to determine recrudescence versus
reinfection in follow-up samples. An initial msp2 typing
was followed by msp1 typing. Successful amplification in
paired samples was achieved in 53 (91.4%) and 52
(89.7%) children by CE and gel electrophoresis, respec-
tively. Classifying outcomes based on msp2, resulted in 11
and 13 recrudescent cases and 41 and 38 new infections
using CE and gel electrophoresis, respectively. When out-
comes were reclassified by adding data from the msp1 gen-
otyping, the same five infections were considered
recrudescent by both techniques (Table 4).
Msp2 IC-type fragments separated with electrophoresis on agarose gel and the corresponding bp size determined by CE and GeneMapper® softwareFigure 3
Msp2 IC-type fragments separated with electrophoresis on agarose gel and the corresponding bp size deter-
mined by CE and GeneMapper® software. MW: 100 base-pair DNA ladder.
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Table 3: Msp1 and msp2 genotyping by CE and gel electrophoresis of 240 microscopy P. falciparum-positive samples from 
asymptomatic children
Capillary electrophoresis Gel electrophoresis
msp1 msp2 msp1 msp2
K1 MAD20 RO33 total FC27 IC total K1 MAD20 RO33 total FC27 IC total
PCR 
positive
195 129 124 223 169 204 223 197 129 126 223 166 201 223
Fragmentsa 314 160 124 598 230 415 645 225 147 126 498 191 253 444
Frequencyb 33 14 1 48 20 76 96 n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Meanc
(95%CI)
1.61 1.24 1.0 2.68
(2.50–2.86)
1.37 2.03 2.89
(2.66–3.13)
1.14 1.14 1.0 2.23
(2.11–2.36)
1.15 1.26 1.99
(1.89–2.09)
a Total number of detected msp1 and msp2 fragments
b number of different alleles detected in all samples, size bins of 3 bp
c Number of alleles/sample, excluding all parasite-negative samples
n.d. not determined
Table 4: Stepwise genotyping of msp2 and msp1 in paired samples collected from children with uncomplicated P. falciparum malaria 
participating in an anti-malarial drug trial in Zanzibar.
msp2 msp1
Outcome Child (study ID) Daya FC27b ICb K1b MAD20b RO33b
Recrudescences K152 0 - 599.84
505.26
- - 157.51
K152 21 - 599.76 - - 157.50
K97 0 - 559.63 246.15 - -
K97 21 - 559.62 246.05 - -
M107 0 - 523.93 - 220.00 -
M107 21 - 523.93 - 220.00 -
M131 0 - 487.40 - 202.01 -
M131 21 - 487.33 - 202.01 -
M152 0 - 528.70 219.25 - -
M152 21 - 528.61 219.26 - -
New infections K108 0 336.25 515.38 - - 157.53
K108 42 336.25 - 246.43 - -
K149 0 336.30 452.49 182.77 201.89 -
K149 28 336.24 580.85 300.79 210.91 -
M161 0 336.30 531.02 138.73
146.36
210.81
220.07
-
M161 21 335.75
419.85
622.87 182.72
210.17
192.88 157.62
M164 0 336.30
419.71
632.64
620.97
228.45 - -
M164 28 336.30 560.93 255.70
264.91
- 157.53
M165 0 335.91
373.27
464.33 210.07 210.81 157.61
M165 28 372.97
419.71
- 228.28 - -
M173 0 372.85 531.85 246.31 220.0
228.15
-
M173 42 372.14 499.35
564.54
201.10
264.10
246.88 -
Outcome classified by msp2 followed by msp1 genotyping to confirm recrudescence (bold) or new infection.
a Paired blood samples collected before initiation of anti-malarial treatment (day 0) and at day of recurrent parasitaemia (days 21–42)
b Fragment sizes in bp
- negative result
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Discussion
A widely used method for genotyping msp1 and msp2 of P.
falciparum parasites was here adapted to multi-coloured
capillary electrophoresis (CE) [7,16] resulting in
improved size resolution as well as throughput compared
to the original gel electrophoresis-based assay. Although
substantial optimization to overcome various artifacts
and practice in interpretation was required, CE clearly rep-
resents an improved technique for fragment sizing com-
pared to sizing by gel electrophoresis.
One of the major advantages of CE is its precision in dis-
tinguishing fragment sizes to the order of single base
pairs. Although gel electrophoresis is a relatively simple
method to perform, size determination of PCR products is
restricted by low resolution. While small differences
between fragments < 10–20 bp may be distinguished by
naked eye, the exact fragment size is difficult, if not impos-
sible, to determine, especially with increasing distances to
the size marker (illustrated in Figure 3). Moreover, inter-
preting the number of bands may vary between different
readings [19]. Even with the aid of software used for size
calling, variations in repeated measurements (2–16 bp)
were observed in this study. To achieve a higher discrimi-
nation power, an alternative method based on RFLP has
been used to analyse individual patterns of restriction
fragments instead of simply sizing PCR products [20]. The
advantage of PCR-RFLP compared to standard gel electro-
phoresis laid in the higher resolution of the generally
small restriction fragments; however, a major disadvan-
tage was the highly complex banding patterns generally
found in areas of high malaria endemicity and high mul-
tiplicity of infection. In the CE assay, a size marker is
added to each individual sample, which allows for high
precision and reproducibility in sizing. Indeed, in this
study size calling of individual alleles differed only by <
0.5–1 bp within and between separate PCR and CE runs,
as well as between different instruments.
The sensitivity of detection of single laboratory lines was
similar between CE and gel electrophoresis, with success-
ful detection of 5 to 10 parasites/μl. The CE method was,
however, better at detecting multiple alleles in laboratory
and field samples. Similar finding was reported in a study
from a different area in Ghana when another CE-based
method for msp2 genotyping was compared to a PCR-
RFLP assay [13]. Detection of these additional alleles may
be explained by the higher resolution of CE, which ena-
bles distinction of the extensive diversity of the msp1 and
msp2 genes that is not detected by gel electrophoresis. The
high number of alleles distinguished here among
Ghanian children indeed reveals an extensive polymor-
phism in this population. To determine allele frequencies,
fragments were allocated to size bins of 3 bp since msp1
and msp2 are coding genes. When applying this strict allele
definition for determining allele frequencies the 127 msp2
IC fragments resulted in 76 different alleles. Fragments
allocated to the same size bin may still differ in sequence
and represent separate alleles.
The CE method showed a high specificity in the analysis
of infections with high parasite densities, whereas gel-
based analyses often generated non-specific bands and
smears (Figure 2), thus complicating the interpretation,
especially in studies of clinical malarial infections. These
larger, non-specific fragments are likely to be caused by
improper re-annealing after PCR amplification reaches
plateau, which may result in misaligned PCR fragments of
higher molecular weight that are detected by gel electro-
phoresis [21]. The larger, non-specific bands are not
detected under denaturated conditions during CE, as
demonstrated by the detection of one single peak in mon-
oclonal infections independent of parasite densities (Fig-
ure 2). Carry-over products from the primary PCR may
also result in larger non-specific bands. However, most
non-specific fragments detected on gels were too small to
represent amplification products from the primary PCR of
the msp genes.
The ability to distinguish recrudescent parasites from new
infections in an anti-malarial drug trial was similar by CE
and gel electrophoresis, resulting in the same outcome
classification. All sizes estimated by CE had high precision
and the interpretation was straightforward. Fragments of
the same length may, however, still represent different
clones considering that the methods only provide the
length and not the sequence of the PCR products [13].
However, the probability of two alleles being classified as
the same is smaller using CE. Interpretation of gels by the
naked eye is more subjective and requires that paired sam-
ples from an individual, collected before treatment and
during follow up, are run in adjacent lanes on the same
gel. A great advantage with CE is that samples can be ran-
domly set up in the 96-well plates, simplifying handling
and decreasing the risk of cross-contamination. The repro-
ducibility of the method also allows for the determination
of allele frequencies in a study population. In the MMV/
WHO guidelines for genotyping in anti-malarial drug tri-
als, CE-based methods are recommended for fragment
analysis [1]. The advantage of the method presented here
is its origin in a well-established genotyping protocol [16]
with the same primers both in the fluorescent and the
original assay.
Quantifying the proportion of different clones within an
infection is of particular interest in studies of within-host
dynamics and can be used, for example, to study if a dom-
inant clone is the cause of a clinical episode of malaria. A
CE-based msp2 genotyping assay with single non-allele
specific PCR, has previously been used to quantify the
proportions of clones in individuals over time [14] Quan-
tification by PCR is preferably determined during the
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exponential phase of a single round of amplification. This
is supported by the poor accuracy of quantification in
mixtures with multiple and different types of lines using
the current nested PCR, and therefore quantification is
not recommended by this method.
Setting up the CE method required extensive optimization
of the original PCR protocols to overcome different types
of artifacts. Although methods must always be adjusted to
individual laboratories, the process reported here may be
useful for other researchers who wish to adapt CE geno-
typing assays. In essence, the modifications involved
primer concentrations and number of cycles in the nested
PCR, diluting the final products in sterile water prior to
CE, and setting a cut-off value of 300 rfu [13]. The charac-
teristic companion peaks, so far observed in only a few
runs, are probably of fluorescent origin and were removed
by diluting the PCR products prior to CE. In completely
automated assays, these artifact peaks may cause a prob-
lem since their rfu values may well be above the set cut-
off. Also, the stutter peaks may coincide with true allele
peaks; however, the stutters often constitute < 10% of the
height of the true allele, and if high intensity peaks appear
within these patterns they should be considered as true
alleles. The repetitive stutter peaks are likely to represent
slippage of Taq DNA polymerase during template exten-
sion [22], resulting in stutter fragments lacking one or sev-
eral of the repetitive units. Although decreasing the
number of PCR cycles in the nested reaction reduced their
frequency, they were not completely eliminated through
any optimization step. In view of these artifacts, we rec-
ommend that all electropherograms be initially screened
manually.
When setting up the CE-based assay, the aim was to opti-
mize throughput to reduce time and costs, as well as to
simplify handling. This included (i) the use of 96-well
plates in all consecutive steps from DNA extraction to CE;
(ii) multiplex amplification of the outer msp1 and msp2
blocks in the primary reaction; (iii) multiplexing the CE
runs with three and two colours for msp1 and msp2,
respectively; and (iiii) multiplexing the nested PCR for
msp1 and msp2. For msp1, the typing results correlated well
between the simplex and multiplex nested assays. How-
ever, for the msp2 marker, a higher number of fragments
were detected by the multiplex approach. Some of these
fragments might have been genetic hybrids [23], however
most were likely artifacts including in vitro recombination
[24]. Except for the msp2 nested PCR, all steps of CE-based
genotyping could thus be multiplexed to increase
throughput. The cost of the CE based genotyping assay
was similar to gel based genotyping, including reagents
(PCR primers, size marker etc) and excluding equipment
(e.g. DNA sequencer) and personnel.
Conclusion
The CE-based genotyping assay described in this report
allowed for precise and highly reproducible typing and
sizing of P. falciparum msp1 and msp2 alleles. There is how-
ever several artifacts, inherent with fluorescence, that need
to be consider in the interpretation and optimization
process. The improved sensitivity and specificity of allelic
discrimination makes the technique an important tool in
future molecular epidemiology studies as well as anti-
malarial drug trials. Additionally, more detailed and reli-
able determination of alleles will also contribute to the
knowledge of the frequency of the different allelic types of
msp1 and msp2 in different epidemiological setting
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